Pharma BD Deal Intelligence

Johnson & Johnson / Abbott Laboratories (Abbott Medical Optics)

2016 · Asset Purchase · $4.3B · Complete

Announcement Sentiment

Strongly positive

Abbott agreed to sell Abbott Medical Optics to Johnson & Johnson for $4.325B all-cash. AMO's portfolio: cataract surgery, laser refractive surgery, and consumer eye health products with $1.1B annual sales. Combined with J&J's ACUVUE Brand Contact Lenses to form Johnson & Johnson Vision. Closed February 2017.

Did it work? Outcome assessment

Strategic verdict

Partially Achieved

Financial impact

Neutral

Pipeline outcome

Assets Advanced

Assessment window: 5yr post-close.

Key facts

Announced Sep 16, 2016
Closed Feb 27, 2017
Deal value $4.3B
Deal type Asset Purchase
Therapeutic area Ophthalmology (cataract, refractive, consumer eye care)
Indications Ophthalmology (cataract, refractive, consumer eye care)
Key assets Abbott Medical Optics (vision care: cataract surgery, laser refractive surgery, consumer eye health)
Mechanism Surgical and consumer ophthalmic devices

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals